| Product NDC: | 0179-0126 |
| Proprietary Name: | EDECRIN |
| Non Proprietary Name: | ethacrynic acid |
| Active Ingredient(s): | 25 mg/1 & nbsp; ethacrynic acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0179-0126 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016092 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130110 |
| Package NDC: | 0179-0126-70 |
| Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0126-70) |
| NDC Code | 0179-0126-70 |
| Proprietary Name | EDECRIN |
| Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0126-70) |
| Product NDC | 0179-0126 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ethacrynic acid |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130110 |
| Marketing Category Name | NDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | ETHACRYNIC ACID |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |